Please use this identifier to cite or link to this item:
|Scopus||Web of Science®|
|Title:||Biotin analogues with antibacterial activity are potent inhibitors of biotin protein ligase|
|Author:||Soares da Costa, T.|
|Citation:||ACS Medicinal Chemistry Letters, 2012; 3(6):509-514|
|Publisher:||American Chemical Society|
|Tatiana P. Soares da Costa, William Tieu, Min Y. Yap, Ondrej Zvarec, Jan M. Bell, John D. Turnidge, John C. Wallace, Grant W. Booker, Matthew C. J. Wilce, Andrew D. Abell, and Steven W. Polyak|
|Abstract:||There is a desperate need to develop new antibiotic agents to combat the rise of drug-resistant bacteria, such as clinically important Staphylococcus aureus. The essential multifunctional enzyme, biotin protein ligase (BPL), is one potential drug target for new antibiotics. We report the synthesis and characterization of a series of biotin analogues with activity against BPLs from S. aureus, Escherichia coli, and Homo sapiens. Two potent inhibitors with K i < 100 nM were identified with antibacterial activity against a panel of clinical isolates of S. aureus (MIC 2-16 μg/mL). Compounds with high ligand efficiency and >20-fold selectivity between the isozymes were identified and characterized. The antibacterial mode of action was shown to be via inhibition of BPL. The bimolecular interactions between the BPL and the inhibitors were defined by surface plasmon resonance studies and X-ray crystallography. These findings pave the way for second-generation inhibitors and antibiotics with greater potency and selectivity.|
|Keywords:||biotin protein ligase; enzyme; enzyme inhibitor; antibiotic; medicinal chemistry|
|Rights:||© 2012 American Chemical Society|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.